Literature DB >> 843708

Turning behaviour elicited by apomorphine, (+)-amphetamine and three ergot derivatives in rats treated with a unilateral injection of ethanolamine-O-sulphate in the substantia nigra [proceedings].

A L Jaton, D M Loew, J M Vigouret.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 843708      PMCID： PMC1667932     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  6 in total

1.  Proceedings: Comparison of circling behaviour following unilateral inhibition of GABA-transaminase or discrete electroyltic lesioning in the rat substantia nigra.

Authors:  A Dray; L J Fowler; N R Oakley; M A Simmonds; T Tanner
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Rotational behaviour following inhibition of GABA metabolism unilaterally in the rat substantia nigra.

Authors:  N R Oakley; M A Simmonds
Journal:  J Pharm Pharmacol       Date:  1975-08       Impact factor: 3.765

3.  Proceedings: CF 25-397 (9, 10-didehydro-6-methyl-8beta-(2-pyridylthiomethyl) ergoline), a new central dopamine receptor agonist.

Authors:  A L Jaton; D M Loew; J M Vigouret
Journal:  Br J Pharmacol       Date:  1976-03       Impact factor: 8.739

4.  Role of -aminobutyric acid (GABA) in the extrapyramidal motor system. 2. Some evidence for the existence of a type of GABA-rich strio-nigral neurons.

Authors:  J S Kim; I J Bak; R Hassler; Y Okada
Journal:  Exp Brain Res       Date:  1971       Impact factor: 1.972

5.  Effects of globus pallidus lesions and Parkinson's disease on brain glutamic acid decarboxylase.

Authors:  P L McGeer; E G McGeer; J A Wada; E Jung
Journal:  Brain Res       Date:  1971-09-24       Impact factor: 3.252

6.  Active-site-directed irreversible inhibition of rat brain 4-aminobutyrate aminotransferase by ethanolamine O-sulphate in vitro and in vivo.

Authors:  L J Fowler; R A John
Journal:  Biochem J       Date:  1972-11       Impact factor: 3.857
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.